Robshaw & Julian Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.18M Buy
68,377
+2,437
+4% +$148K 3% 14
2017
Q1
$4M Sell
65,940
-2,059
-3% -$125K 2.89% 16
2016
Q4
$3.82M Sell
67,999
-446
-0.7% -$26.1K 2.82% 18
2016
Q3
$4.08M Hold
68,445
3.03% 16
2016
Q2
$3.76M Sell
68,445
-12,340
-15% -$657K 2.87% 17
2016
Q1
$4.08M Buy
80,785
+2,096
+3% +$103K 3.07% 15
2015
Q4
$3.97M Buy
78,689
+6,719
+9% +$339K 3.07% 16
2015
Q3
$3.39M Buy
71,970
+24,355
+51% +$1.29M 2.87% 19
2015
Q2
$2.59M Buy
+47,615
New +$2.67M 1.99% 24

Other funds holding MRK

Robshaw & Julian Associates's MRK Position: Q2 2017 in Review

Robshaw & Julian Associates increased its Merck (MRK) stake by 3.7% in Q2 2017, buying an estimated $148K and bringing the position to 68,377 shares worth $4.18M. The position accounts for 3% of the portfolio, ranked #14.

Robshaw & Julian Associates first reported a position in MRK in Q2 2015 and has held it in 9 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Robshaw & Julian Associates held 68,377 shares of Merck worth $4.18M as of Q2 2017.
  • Robshaw & Julian Associates bought 2,437 Merck shares in Q2 2017, an estimated $148K.
  • Merck made up 3% of Robshaw & Julian Associates's portfolio in Q2 2017, its #14 holding.
  • Robshaw & Julian Associates first reported a position in Merck in Q2 2015 and has held it in 9 quarters since.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.